Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study. (Q51843234)
Jump to navigation
Jump to search
scientific article published on 17 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study. |
scientific article published on 17 November 2011 |
Statements
Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study. (English)
1 reference
1 reference
Dirk De Ruysscher
1 reference
Angela van Baardwijk
1 reference
Anne-Marie C Dingemans
1 reference
Geert Bosmans
1 reference
Rinus Wanders
1 reference
Jacques Borger
1 reference
Michel Oellers
1 reference
Jessie Steevens
1 reference
Anita Botterweck
1 reference
Bart Reymen
1 reference
Cordula Pitz
1 reference
Ragnar Lunde
1 reference
Wiel Geraedts
1 reference
Gerben Bootsma
1 reference
Philippe Lambin
1 reference
17 November 2011
1 reference
102
1 reference
2
1 reference
228-233
1 reference